YI4 Different patterns of telomerase reverse transcriptase (hTERT) mRNA variant expression profiles in patients with myelodysplastic syndromes

Autor: Verrou, E., Kaloutsi, V., Katodritou, E., Gastari, V., Banti, A., Nikitidou, A., Garypidou, V., Zervas, K., Kotoula, V.

Publikováno v: In Leukemia Research 2009 33 Supplement 1:S57-S57

Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group

Autor: Katodritou, E. Terpos, E. Kelaidi, C. Kotsopoulou, M. Delimpasi, S. Kyrtsonis, M.-C. Symeonidis, A. Giannakoulas, N. Stefanoudaki, A. Christoulas, D. Chatziaggelidou, C. Gastari, V. Spyridis, N. Verrou, E. Konstantinidou, P. Zervas, K. Dimopoulos, M.A.

Plasma cell leukemia (PCL) is a rare and aggressive plasma cell disorder, with poor outcome. Bortezomib-based regimens (BBR) are highly effective in myeloma, but there is limited information about their efficacy and safety in PCL. Thus, we retrospect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::0dc1019b3bac1a75ac6c86ba969c8df8
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3126967

Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome?

Autor: Katodritou, E., Gastari, V., Verrou, E., Hadjiaggelidou, C., Varthaliti, M., Georgiadou, S., Laschos, K., Xirou, P., Yiannaki, E., Constantinou, N., Markala, D., Zervas, K.

Publikováno v: In Leukemia Research 2009 33(8):1137-1140

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience.

Autor: Katodritou E; Greek Myeloma Study Group, Athens, Greece. eirinikatodritou@gmail.com.; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece. eirinikatodritou@gmail.com., Terpos E; Greek Myeloma Study Group, Athens, Greece.; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Kastritis E; Greek Myeloma Study Group, Athens, Greece.; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Delimpasis S; Greek Myeloma Study Group, Athens, Greece.; Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece., Symeonidis AS; Greek Myeloma Study Group, Athens, Greece.; Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece., Repousis P; Greek Myeloma Study Group, Athens, Greece.; Department of Hematology, Metaxa Cancer Hospital, Piraeus, Greece., Kyrtsonis MC; Greek Myeloma Study Group, Athens, Greece.; First Propedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Vadikolia C; Department of Hematology, 424 General Military Hospital, Thessaloniki, Greece., Michalis E; Greek Myeloma Study Group, Athens, Greece.; Department of Hematology, Geniko Kratiko General Hospital, Athens, Greece., Polychronidou G; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece., Michael M; Greek Myeloma Study Group, Athens, Greece.; Department of Hematology, General Hospital, Lefkosia, Cyprus., Papadaki S; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece., Papathanasiou M; Greek Myeloma Study Group, Athens, Greece.; Department of Hematology-Bone Marrow Transplantation Unit, George Papanicolaou Hospital, Thessaloniki, Greece., Kokoviadou K; Greek Myeloma Study Group, Athens, Greece.; Department of Hematology, Papageorgiou General Hospital, Thessaloniki, Greece., Kioumi A; Department of Hematology, Papageorgiou General Hospital, Thessaloniki, Greece., Vlachaki E; Greek Myeloma Study Group, Athens, Greece., Hadjiaggelidou C; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece., Kouraklis A; Greek Myeloma Study Group, Athens, Greece.; Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece., Patsias I; Department of Hematology, Metaxa Cancer Hospital, Piraeus, Greece., Gavriatopoulou M; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Kotsopoulou M; Greek Myeloma Study Group, Athens, Greece.; Department of Hematology, Metaxa Cancer Hospital, Piraeus, Greece., Verrou E; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece., Gastari V; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece., Christoulas D; Greek Myeloma Study Group, Athens, Greece.; Department of Hematology, 251 General Air Force Hospital, Athens, Greece., Giannopoulou E; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece., Pouli A; Greek Myeloma Study Group, Athens, Greece., Konstantinidou P; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece., Anagnostopoulos A; Greek Myeloma Study Group, Athens, Greece.; Department of Hematology-Bone Marrow Transplantation Unit, George Papanicolaou Hospital, Thessaloniki, Greece., Dimopoulos MA; Greek Myeloma Study Group, Athens, Greece.; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Publikováno v: Annals of hematology [Ann Hematol] 2015 Dec; Vol. 94 (12), pp. 2033-42. Date of Electronic Publication: 2015 Sep 30.

Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group.

Autor: Katodritou E; Hematology Department, Theagenion Cancer Hospital, Thessaloniki, Greece., Terpos E, Kelaidi C, Kotsopoulou M, Delimpasi S, Kyrtsonis MC, Symeonidis A, Giannakoulas N, Stefanoudaki A, Christoulas D, Chatziaggelidou C, Gastari V, Spyridis N, Verrou E, Konstantinidou P, Zervas K, Dimopoulos MA

Publikováno v: American journal of hematology [Am J Hematol] 2014 Feb; Vol. 89 (2), pp. 145-50. Date of Electronic Publication: 2013 Nov 21.